Skip to main content
. 2012 Oct 17;2012:642576. doi: 10.1155/2012/642576

(b)  

Author Sample Cancer Type
and Treatment
Yoga Intervention Outcome Measures
Reported in Current Review
Bower et al., 2011 [18] T1 = 12, T2 = 11
Age range: 46–65
Mean age = 54
Breast (Stages 0–2)
All had completed radiation therapy or radiation therapy + chemotherapy
90-minute classes twice weekly for 12 weeks
Type: Iyengar Yoga
Quality of Life
-SF-36
Psychosocial
-BDI-II
Symptom
-PSQI, FSI

Danhauer et al., 2008 [19] T1 = 51, T2 = 43
Age range: 34–82
Mean age = 59
Ovarian (n = 37)
Breast (n = 14)
Radiation therapy (n = 5)
Chemotherapy (n = 29)
75-minute weekly classes for 10 weeks
Type: Integral Yoga
Quality of Life
-FACT-G, SF-12
Psychosocial
-CES-D, FACIT-Sp, PANAS, STAI
Symptom
-FACT-F

Duncan et al., 2008 [20] T1 = 24, T2 = 22
Age range: NR
Mean age = 49
Breast (42%)
Gynecologic (16.6%)
Lymphoma (12.5%)
Currently on or <6 months post treatment
90 minute weekly classes for 10 weeks
Type: Iyengar Yoga
Quality of Life
-FACT-G
Psychosocial
-FACIT-Sp

Galantino et al., 2011 [21] T1 = 10, T2 = 10
Age range: 50–71
Median age = 58
Breast (Stages I–III)
>4 weeks post-chemotherapy and/or post-radiation, all women taking aromatase inhibitors
90-minute classes twice weekly for 8 weeks, home practice encouraged
Type: Iyengar-inspired
Quality of Life
-FACT-B

Speed-Andrews et al., 2010 [22] T1 = 17, T2 = 17
Age range: not reported
Mean age = 54
Breast (Stages I–III)
Surgery (n = 23)
Radiation therapy (n = 19)
Chemotherapy (n = 18)
Hormone therapy (n = 10)
Two different sessions; 90 minute classes twice weekly for 6 weeks and 90 minute classes 22 times over 12 weeks
Type: Iyengar Yoga
Quality of Life
-FACT-B, SF-36
Psychosocial
-CES-D, STAI

Ülger and Yağlı, 2010 [23] T1 = 20, T2 = 20
Age range: 30–50
Mean age = 41
Breast
>6 months post-chemotherapy
60 minute weekly classes for 8 weeks
Type: Not specified (“Classical Yoga”)
Quality of Life
-NHP
Psychosocial
-STAI

Abbreviations: T1: baseline; T2: follow-up; SF-36 and SF-12: Medical Outcomes Study Short-Form Health Survey; EORTC QLQ C30: European Organization for Research and Treatment of Cancer-Quality of Life C30; FACT-B: Functional Assessment of Cancer Therapy—Breast; FACT-G: Functional Assessment of Cancer Therapy—General; NHP: Nottingham Health Profile; BDI: Beck Depression Inventory; CES-D 20: Center for Epidemiologic Studies Depression Scale—20 Item; STAI: State/Trait Anxiety Inventory; POMS: Profile of Mood States; PANAS: Positive and Negative Affect Schedule; FACIT-Sp: Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being; HADS: Hospital Anxiety and Depression Scale; BFI: Brief Fatigue Inventory; PSQI: Pittsburgh Sleep Quality Index; FSI: Fatigue Symptom Inventory; FACT-F: Functional Assessment of Cancer Therapy-Fatigue. NR: Not Reported.